Skip to main content
OpenTrials

Clinical trial condition

Hereditary Sensory and Autonomic Neuropathies

Explore clinical trials studying Hereditary Sensory and Autonomic Neuropathies. Study availability and eligibility vary by location and protocol.

116 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Sensory and Autonomic Neuropathies trial results

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 82 locations
View Trial Details
Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +40 more
Locations
  • Ellison Clinic at Saint John's Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 65 locations
View Trial Details
Recruiting

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

NCT07558733

Conditions
Breast Diseases, Breast Neoplasms, Congenital Abnormalities, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Oncology Associates of Oregon Springfield, Oregon, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT06993844

Conditions
Adnexal Diseases, Advanced Breast Cancer, Advanced Solid Tumors, +40 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

NCT07175038

Conditions
Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • University of California Davis Health Rancho Cordova, California, United States
  • University of Colorado Aurora, Colorado, United States
  • George Washington University Medical Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

NCT05010031

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details

Related conditions